Correction: Development and evaluation of rapid data-enabled access to routine clinical information to enhance early recruitment to the national clinical platform trial of COVID-19 community treatments (Trials, (2022), 23, 1, (62), 10.1186/s13063-021-05965-4)
Journal article
Cake C. et al, (2023), Trials, 24
Informed consent in randomised controlled trials: further development and evaluation of the participatory and informed consent (PIC) measure
Journal article
Wade J. et al, (2023), Trials, 24
A targeted approach to vaccine hesitancy
Journal article
Leston M. et al, (2023), Oxford Open Immunology
COVID-19 vaccine effectiveness against hospitalisation and death of people in clinical risk groups during the Delta variant period: English primary care network cohort study
Journal article
Whitaker HJ. et al, (2023), Journal of Infection, 87, 315 - 327
The drivers of non-adherence to albuminuria testing guidelines and the clinical and economic impact of not identifying chronic kidney disease.
Journal article
Groehl F. et al, (2023), Clin Nephrol, 100, 145 - 156
Predicting the risk of acute kidney injury in primary care: derivation and validation of STRATIFY-AKI
Journal article
Koshiaris C. et al, (2023), The British journal of general practice : the journal of the Royal College of General Practitioners, 73, e605 - e614
Evaluation of the diagnostic accuracy of two point-of-care tests for COVID-19 when used in symptomatic patients in community settings in the UK primary care COVID diagnostic accuracy platform trial (RAPTOR-C19)
Journal article
Nicholson BD. et al, (2023), PLoS ONE, 18
Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study
Journal article
Nicholson BD. et al, (2023), The Lancet Oncology, 24, 733 - 743
Development of a modified Cambridge Multimorbidity Score for use with SNOMED CT: an observational English primary care sentinel network study
Journal article
Tsang RSM. et al, (2023), British Journal of General Practice, 73, E435 - E442
Body mass index and survival in people with heart failure
Journal article
JONES N. et al, (2023), Heart
The association between antihypertensive treatment and serious adverse events by age and frailty: A cohort study
Journal article
Sheppard JP. et al, (2023), PLOS Medicine, 20, e1004223 - e1004223
Long-Term Effect of Weight Regain Following Behavioral Weight Management Programs on Cardiometabolic Disease Incidence and Risk: Systematic Review and Meta-Analysis.
Journal article
Hartmann-Boyce J. et al, (2023), Circ Cardiovasc Qual Outcomes
Evaluating the transmission risk of SARS-CoV-2 from sewage pollution
Journal article
Ransome E. et al, (2023), Science of the Total Environment, 858
Weight regain after behavioural weight management programmes and its impact on quality of life and cost effectiveness: Evidence synthesis and health economic analyses
Journal article
Hartmann-Boyce J. et al, (2023), Diabetes, Obesity and Metabolism, 25, 526 - 535
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
Journal article
Butler CC. et al, (2023), The Lancet, 401, 281 - 293
COVID-19 booster vaccination uptake and infection breakthrough amongst health care workers in Wales: A national prospective cohort study.
Journal article
Bedston S. et al, (2023), Vaccine
BLOod Test Trend for cancEr Detection (BLOTTED): protocol for an observational and prediction model development study using English primary care electronic health record data.
Journal article
Virdee PS. et al, (2023), Diagn Progn Res, 7
Face masks while exercising trial (MERIT): a cross-over randomised controlled study
Journal article
Jones N. et al, (2023), BMJ open, 13
Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self-controlled case series study
Journal article
Tsang RS. et al, (2023), Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 28
Analysis of SARS-CoV-2 Emergent Variants Following AZD7442 (Tixagevimab/Cilgavimab) for Early Outpatient Treatment of COVID-19 (TACKLE Trial)
Journal article
Kijak GH. et al, (2023), Infectious Diseases and Therapy